Iceland - Lipid Modifying Medicine Use
Since 2014, Iceland Lipid Modifying Medicine Use jumped by 1.7% year on year. In 2019, the country was number 21 among other countries in Lipid Modifying Medicine Use with 95.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Iceland is overtaken by Slovakia, which was ranked number 20 with 96.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Austria with 94.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.5% versus 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania recorded the best 5 years average growth at +18.8% per year, while Slovakia recorded the worst performance at -8.7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 95.10 |
| 2018 | 93.40 |
| 2017 | 93.00 |
| 2016 | 91.10 |
| 2015 | 90.30 |
How does Iceland rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 20 |
#20
Slovakia
|
97 | 2019 | +3.6 % | -8.7 % | View data | |
| 21 |
#21
Iceland
|
95 | 2019 | +1.8 % | +1.7 % | View data | |
| 22 |
#22
Austria
|
94 | 2019 | +0.8 % | +5.3 % | View data | |